H. Oya Alpar

Development and characterisation of chitosan nanoparticles for siRNA delivery

Haliza Katas, H. Oya Alpar · Journal of Controlled Release · 2006 · 642 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutical Biotechnology +14

Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge

A.K. Kohli, H. Oya Alpar · International Journal of Pharmaceutics · 2004 · 286 citations

Pharmacy, Biomedical Engineering, Pharmaceutics +16

Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery

Burak Sayın, Satyanarayana Somavarapu, XW Li et al. · International Journal of Pharmaceutics · 2008 · 178 citations

Pharmacy, Biotechnology, Pharmaceutics +16

Development and initial evaluation of a real-time RT-PCR assay to detect bluetongue virus genome segment 1

Andrew E. Shaw, Padraic Monaghan, H. Oya Alpar et al. · Journal of Virological Methods · 2007 · 154 citations

Life Sciences, Microbiology, Molecular Biology +14

Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems

J. B. Singh, Sreenivas Pandit, Vincent W. Bramwell et al. · Methods · 2006 · 116 citations

Pharmacy, Immunology, Pharmaceutics +14